VRTX
$VRTX
Vertex Pharmaceuticals
Biotech leader in cystic fibrosis treatments and pain therapies.
Healthcare$446.83
+5.09 (+1.15%)
Day Range$443.86 - $453.16
Prev Close$441.74
Analyst Rating
Strong Buy
33 Buy / 6 Hold / 1 Sell
Subscribers
0
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
VRTX — Pipeline Progress and Durable CF Franchise
Vertex ($VRTX) combines a dominant cystic fibrosis franchise with expanding non-CF programs and strong analyst support. Recent beats and regulatory submissions underpin upside, while valuation and execution risk remain key checks.
May 31, 2026